Iron oxide-enhanced MR lymphography: Initial experience

European Journal of Radiology

Volumn 34, Issue 3, 2000, Pages 257-264

  Bellin, Marie France ^a   Beigelman, Catherine ^a   Precetti Morel, Sophie ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Contrast enhancement; Lymphatic system; Lymphatic system, MR; Magnetic resonance (MR); Neoplasms

Indexed keywords

CARDIOVASCULAR SYSTEM; CONTRAST MEDIA; IMAGE ENHANCEMENT; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MAGNETIC SUSCEPTIBILITY; ONCOLOGY; PHYSIOLOGY;

CONTRAST ENHANCEMENT; LYMPHATIC SYSTEM; MAGNETIC RESONANCE LYMPOGRAPHY; NEOPLASMS; ULTRASMALL SUPERMAGNETIC IRON OXIDE PARTICLE;

DIAGNOSTIC RADIOGRAPHY;

NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CAPILLARY PERMEABILITY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; HUMAN; IMAGE QUALITY; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHOGRAPHY; MAGNETISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

CONTRAST MEDIA; HUMANS; INJECTIONS, INTRAVENOUS; IRON COMPOUNDS; LYMPHATIC METASTASIS; LYMPHOGRAPHY; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING;

EID: 0033868519     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(00)00204-7     Document Type: Article

References (24)

1. Weissleder R., Elizondo G., Wittenberg J., Rabito C.A., Bengele H.H., Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology. 175:1990;489-493.
2. Lee A.S., Weissleder R., Brady T.J., Wittenberg J. Lymph nodes: microstructural anatomy at MR imaging. Radiology. 178:1991;519-522.
3. Guimaraes R., Clement O., Bittoun J., Carnot F., Frija G. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement. Am. J. Roentol. 162:1994;201-207.
4. Tanoura T., Bernas M., Darkazanli A., Elam E., Unger E., Witte M.H., Green A. MR lymphography with iron oxide compound AMI-227: studies in ferrets with filariasis. Am. J. Roentol. 159:1992;875-881.
5. Anzai Y., Blackwell K.E., Hirschowitz S.L. et al. Initial clinical experience with Dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology. 192:1994;709-715.
6. Anzai Y., McLachlan S., Morris M., Saxton R., Lufkin R.B. Dextran-coated superparamagnetic iron oxide: an MR contrast agent for assessing lymph nodes in the head and neck. AJNR. 15:1994;87-94.
7. Bellin M.F., Roy C., Kinkel K. et al. Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles. Initial clinical experience. Radiology. 207:1998;799-808.
8. Davis G.L. Sensitivity of frozen section examination of pelvic lymph node for metastatic prostate carcinoma. Cancer. 76:1995;661-668.
9. Weissleder R, Heautot JF, Schaffer BK, Nossiff N, Papisov MI, Bogdanov A Jr, Brady TJ. MR lymphography: study of a high-efficency lymphotropic agent. Radiology 1994;191:225-230.
10. Harisinghani M.G., Saini S., Weissleder R. et al. MR lymphography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. Am. J. Roentol. 172:1999;1347-1351.
11. McLachlan S., Morris M.R., Lucas M.A. et al. Phase I clinical evaluation of a new iron oxide MR contrast agent. JMRI. 4:1994;301-307.
12. Bellin M.F., Zaim S., Auberton E., Sarfati G., Duron J.J., Khayat D., Grellet J. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology. 193:1994;657-663.
13. Gretz J., Anderson A., Shaw S. Cords, channels, corridors and conduits: critical architectural elements facilitating interactions in the lymph node cortex. Immunol. Rev. 156:1997;11-24.
14. Chambon C., Clement O., Le Blanche A., Schouman-Claeys E., Frija G. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magn. Reson. Imag. 11:1993;509-519.
15. Bengele HH, Palmacci S, Rogers J, Jung CW, Crenshaw J, Josephson L. Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 18549, by different routes of administration. Magn Reson Imag 1994;12:433-442.
16. Hudgins P.A., Anzai Y., Morris M. Dextran-coated superparamagnetic iron oxide MR contrast agent (CombidexTM) for imaging cervical lymph nodes: optimal dose, time of imaging, and pulse sequence (abstr). Presented at the Los Angeles, American Society of Neuroradiology. Seattle. 1996:1996;269.
17. Anzai Y., Prince M.R. Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer. JMRI. 7:1997;75-81.
18. Gerlowski L.E., Jain R.K. Microvascular permeability of normal and neoplastic tissues. Microvasc. Res. 31:1986;288-305.
19. Harisinghani M.G., Saini S., Slater G.J., Schnall M.D., Rifkin M.D. MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): preliminary observations. JMRI. 7:1997;161-163.
20. Anzai Y, Som PH, Maravilla KR, Hudgins PA, Mukherji SK, Sato Y. Ultrasmall superparamagnetic iron oxide contrast agent for head and neck cancer (abstr). Proccedings of the Radiological Society of North America, Chicago III; 1999; 277.
21. Taupitz M, Hamm BK, Barentsz JO, Vock P, Roy C, Bellin MF. Sinerem®-enhanced MRI imaging compared to plain MR imaging in evaluating lymph node metastases from urologic and gynecologic cancers (abstr). Proceedings of the Radiological Society of North America, Chicago, Ill; 1999; 387.
22. Taupitz M, Wallis F, Heywang-Koebrunner SH, Thibault F, Gilles R, Tardivon AA. Axillary lymph node MR imaging with Sinerem® in patients with suspected breast cancer. (abstr). Proceedings of the Radiological Society of North America, Chicago, IL; 1999; 369.
23. Sigal RC, Vogl TJ, Casselman JW, Moulin GC, Hermans R, Halimi R. Comparison of Sinerem registred MR to plain MR in the diagnosis of lymph node metastases from head and neck cancer (abstr). Proceedings of the Radiological Society of North America, Chicago, IL; 1999;277.
24. Anzai Y., Prince M.R., Chenevert T.L., Maki J.H., McLachlan S.J. MR angiography with a dextran-coated ultrasmall superparamagnetic iron oxide blood pool agent. J. Magn. Reson. Imag. 7:1997;213-218.